---
layout: clqms-post.njk
tags: clqms
title: "Database Design Review: Claude Sonnet"
date: 2025-12-05
order: 5
---

# Database Schema Design Review

**Prepared by:** Claude Sonnet
**Date:** December 12, 2025

## Executive Summary

**Overall Assessment:** ‚ö†Ô∏è **Over-Engineered**

The schema will technically work and can deliver the required functionality, but presents significant challenges.

| Aspect | Rating | Impact |
|--------|--------|--------|
| Functionality | ‚úÖ Will work | Can deliver features |
| Maintainability | ‚ö†Ô∏è Poor | High developer friction |
| Performance | ‚ùå Problematic | Requires extensive optimization |
| Complexity | ‚ùå Excessive | Steep learning curve |
| Scalability | ‚ö†Ô∏è Questionable | Architecture limitations |

---

## Critical Issues

### Issue #1: Excessive Normalization

**Severity:** üü° Medium

Single-field data has been separated into dedicated tables, creating unnecessary complexity.

### Issue #2: Problematic Unique Constraints

**Severity:** üî¥ Critical - Production Blocker

- `EmailAddress1` marked UNIQUE - will break for families sharing emails
- `InternalPID` unique in `patcom` - only allows ONE comment per patient EVER

### Issue #3: Audit Trail Overkill

**Severity:** üü° Medium

Every log table tracks 15+ fields per change, creating massive overhead with unclear benefit.

---

## Recommendations

### üî¥ Critical Priority - Address Immediately

1. Remove problematic unique constraints (EmailAddress1, patcom.InternalPID)
2. Fix incomplete tables (add missing fields to `patrelation`)
3. Document temporal field logic (CreateDate, EndDate, ArchivedDate, DelDate)

### üü° High Priority - Plan for Refactoring

1. Simplify audit trails (reduce 15+ fields to 5-7 essential fields)
2. Consolidate patient data (consider moving to main `patient` table)

---

## Expected Benefits

| Metric | Value |
|--------|-------|
| Total Complexity Reduction | **40-50%** |
| Developer Productivity Gain | **30-40%** |
| Performance Improvement | **2-5x** |

---

*End of Report - Claude Sonnet, December 12, 2025*
